Ross, J.A.; Riccardelli, W.; Robitaille, J.; Levy, S.
Evidence for Cannabidiol as a Medication for the Treatment of Neurological, Psychiatric, Behavioral and Substance Use Disorders in Adolescents. Adolescents 2025, 5, 54.
https://doi.org/10.3390/adolescents5040054
AMA Style
Ross JA, Riccardelli W, Robitaille J, Levy S.
Evidence for Cannabidiol as a Medication for the Treatment of Neurological, Psychiatric, Behavioral and Substance Use Disorders in Adolescents. Adolescents. 2025; 5(4):54.
https://doi.org/10.3390/adolescents5040054
Chicago/Turabian Style
Ross, Jennifer A., William Riccardelli, James Robitaille, and Sharon Levy.
2025. "Evidence for Cannabidiol as a Medication for the Treatment of Neurological, Psychiatric, Behavioral and Substance Use Disorders in Adolescents" Adolescents 5, no. 4: 54.
https://doi.org/10.3390/adolescents5040054
APA Style
Ross, J. A., Riccardelli, W., Robitaille, J., & Levy, S.
(2025). Evidence for Cannabidiol as a Medication for the Treatment of Neurological, Psychiatric, Behavioral and Substance Use Disorders in Adolescents. Adolescents, 5(4), 54.
https://doi.org/10.3390/adolescents5040054